PREDICT

The PREDICT Module is a comprehensive platform that integrates polygenic risk scores (PRS) with clinical risk factors to provide a detailed assessment of an individual’s risk for common complex diseases such as heart disease, cancer, and diabetes. By combining genetic and clinical data, you can deliver personalized, data-driven care that aligns with the latest in genomic medicine.

Benefits for Healthcare Providers

1. Precision Risk Assessment

Go beyond traditional risk factors with PRS-enhanced assessments that provide a deeper understanding of your patient’s genetic predisposition.

2. Personalized Patient Management

Use the PREDICT Module to tailor prevention and management plans based on a comprehensive analysis of genetic and clinical factors, leading to more targeted interventions.

3. Proactive Care Strategies

Early identification of at-risk patients allows for timely, preventive measures, which can significantly improve patient outcomes and reduce the burden of disease.

img

Seamless Integration into Clinical Workflows

The PREDICT Module is designed with physicians in mind, offering an easy-to-navigate platform that integrates seamlessly into your existing workflows. Our intuitive interface and clear reporting make it simple to interpret results and discuss genetic risk with your patients, enhancing shared decision-making. Allelica’s PRS reports are generated using the PREDICT software and are uploaded directly onto the user platform through advanced API integration and seamless communication with electronic health records.

The reports include:
Top-performing PRSs for a range of diseases
Ancestry-specific analysis
10-year risk of disease
Lifetime risk of disease

Why Choose Allelica’s PREDICT Module?

  • Scientifically Validated PRS Models: Allelica’s PRS models are built on robust scientific research and validated for clinical use, providing confidence in the accuracy and applicability of the results.

  • Actionable Reports: Our reports are designed for clarity and actionability, giving you the information you need to make informed clinical decisions that benefit your patients.

  • Provider Support and Resources: We offer comprehensive support and educational resources for healthcare providers, ensuring you stay at the forefront of genomic medicine.

img

PRS BREAST CANCER

(577K variants)


PRS EARLY MENOPAUSE

(523K variants)


PRS OSTEOPOROSIS

(21K variants)

img

PRS BREAST CANCER

(577K variants)


IDENTIFY THE GENETIC CAUSE OF DISEASE IN WOMAN WITH BREAST CANCER


PROVIDE INTEGRATED RISK

(PRS + monogenic) for BRCA1/2, PALB2, CHEK2 carriers


ASSES RISK IN HEALTHY NON-CARRIERS

img

PRS PROSTATE CANCER

(682K variants)


IDENTIFY THE GENETIC CAUSE OF DISEASE IN MEN WITH PROSTATE CANCER


PROVIDE INTEGRATED RISK

(PRS + monogenic)

FOR BRCA2, CHEK2, ATM, HOXB13 CARRIERS


ASSESS RISK IN HEALTHY NON-CARRIERS

img

PRS CORONARY ARTERY DISEASE

(1.9M variants)


PRS HYPERTENSION

(247K variants)


PRS ATRIAL FIBRILLATION (445K variants)


LIPID PANEL: LDL, HDL, LIPOPROTEIN(A), TRIGLYCERIDES


PHARMACOGENOMICS

Seamlessly integrate PREDICT with your Thermo Fisher Axiom workflow

Thermo Fisher Axiom solutions provide cost-effective, customized microarray solutions for disease and drug screening, as well as genetics research. The Axiom PangenomiX Array is a comprehensive array that offers high genomic coverage for studying disease susceptibility, pharmacogenomics, and genetic factors underlying wellness and lifestyle in diverse populations. It includes over 850,000 markers selected from widely referenced public databases such as the 1000Genomes Project Phase III, ClinVar, NHGRI-GWAS catalog, CPIC, and PharmaGKB.

If you are looking for specific markers, you can explore the catalog of Thermo Fisher arrays or discuss affordable array customization options with us.

For additional support in processing samples, the Applied Biosystems™ Microarray Research Services Laboratory (MRSL) is available. This lab offers cost-effective genotyping services, generating high-quality data for academic and research institutions. By utilizing MRSL, you can complete your population studies without the need to increase your lab footprint, hire or train personnel, or purchase additional instruments. MRSL provides quality data analysis to support publication and grant submission, and operates with the same care and attention to detail as your own microarray testing facility.

Reach out to a Thermo Fisher representative to gain access to promotional offers for your population study at www.thermofisher.com/genotypingcontact

Empower Your Practice with Predictive Genomics

Incorporate Allelica's PREDICT Module into your clinical practice and join the forefront of personalized medicine. By integrating predictive genomic insights, you can provide your patients with the most advanced care tailored to their individual risk profiles. Allelica’s Software as a Service consists of three modules:

  • PREDICT for clinical genetics laboratories and health systems

  • DISCOVER for anyone wishing to develop their own PRS

  • VALIDATE which is used to test existing and new scores on an independent dataset

All Allelica’s modules are available on the cloud or on-premises for genetics laboratories to streamline in-house PRS calculation and reporting with a simple file upload.

The easy-to-use interface requires only a few clicks and can produce customized PRS reports within hours. These reports can be uploaded directly into a physician portal or into EHRs using the latest in API integration.

Allelica’s technology is designed to simplify the process of Polygenic Risk Score analysis and reporting. With three simple steps, users can generate highly personalized reports for a range of diseases.

Get Started Today

Ready to enhance your patient care with predictive genomics? Contact us to learn how the PREDICT Module can be seamlessly integrated into your practice, providing you with the tools to deliver personalized, predictive healthcare.

img